CAS: 106896-49-5; Methyl 4-Amino-3-Bromobenzoate

相似化合物

6311-37-1 126759-30-6 3282-10-8

上下游产品

CAS号619-45-4 4-氨基苯甲酸甲酯 | CAS号67-56-1 甲醇 | CAS号6311-37-1 4-氨基-3-溴苯甲酸 | CAS号1032373-56-0 methyl 4-amino-... | CAS号6311-37-1 4-氨基-3-溴苯甲酸 | CAS号619-45-4 4-氨基苯甲酸甲酯 | CAS号162959-43-5 6-Benzothiazole... | CAS号249647-24-3 3-溴-4-碘苯甲酸甲酯 | CAS号1150112-11-0 methyl 3-bromo-... | CAS号119963-45-0 4-(t-butyl)-1-(...

4-氨基苯甲酸甲酯置于氢溴酸,二甲基亚砜体系中,用 水,乙酸乙酯 用作溶剂,化学反应 12.0H,反应生成4-氨基-3-溴苯甲酸甲酯
参考文献:2-乙烯基苯胺和炔烃通过 C≡c 三键裂解和双氧活化直接合成色氨酸
标题:2-乙烯基苯胺和炔烃通过 C≡c 三键裂解和双氧活化直接合成色氨酸
摘要:已经开发出一种意想不到的无金属 C≡c 三键断裂,双氧活化和重新组装成色氨酸衍生物.这种化学反应提供了一种新颖,简单且有效的方法,可以在温和条件下从简单底物获得高价值的色氨酸衍生物.机理研究可能会通过 Cc 键裂解和分子氧活化促进新方法的发现.
Doi:10.1021/jacs.6B08094

专利信息

专利号:US-10005720-B2
优先权日:2013-04-05
标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same
发明人：SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L
权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL
摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.

专利号:US-2018370905-A1
优先权日:2013-04-05
标题:Compounds Useful for the Treatment of Metabolic Disorders and Synthesis of the Same

专利号:US-2016046560-A1
优先权日:2013-04-05
标题 :Compounds useful for the treatment of metabolic disorders and synthesis of the same

专利号:WO-2014165816-A1
优先权日:2013-04-05
标 题 :Compounds useful for the treatment of metabolic disorders and synthesis of the same

专利号:EP-3766543-A1
优先权日:2019-07-19
标 题:N-aryl derivatives for treating a rna virus infection
权利人:ABIVAX; CENTRE NAT RECH SCIENT; UNIV MONTPELLIER; INST CURIE
摘要:wherein: nX 2 represents a -CO-NRk- group, a -NR'k-CO- group, a -O- group, a -CO- group, a -SO 2 -group, a -CS-NH- group, a -CH 2 -NH-, an ngroup, or a divalent 5-membered heteroaromatic ring comprising 1, 2, 3 or 4 heteroatoms; Y 2 represents a hydrogen atom, a halogen atom, a hydroxyl group, a morpholinyl group, optionally substituted by a (C 1 -C 4 )alkyl group, a piperidinyl group, a (C 1 -C 4 )alkenyl group, a -PO(OR a )(OR b ) group, Or a -CR 1 R 2 R 3 group, or any of its pharmaceutically acceptable salt. n The present invention further relates to new compounds, to pharmaceutical compositions containing them and to synthesis process for manufacturing them.